JORDAN MAYBERRY: Open Payments
NPI 1982940466 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,217 in 41 payments from 4 companies in 2025. Trend: 2023 $1,559 · 2024 $11,429 · 2025 $5,217
Consulting: $4,320Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 33 | $2,604 |
| Madrigal Pharmaceuticals | 5 | $2,512 |
| Mirum Pharmaceuticals, Inc. | 2 | $77 |
| ABBVIE INC. | 1 | $24 |
Products named: REZDIFFRA, Livdelzi, Livmarli, MAVYRET.
Industry payments across TX — which companies pay providers there.
